Figure 1
Overall survival and failure-free survival. Four-year overall survival was 97%, and 4-year failure-free survival was 52%. Failure is defined as death, for overall survival, and as time of next therapy, for failure-free survival.
Overall survival and failure-free survival. Four-year overall survival was 97%, and 4-year failure-free survival was 52%. Failure is defined as death, for overall survival, and as time of next therapy, for failure-free survival.
